Korro Bio
KRRO
85 hedge funds and large institutions have $38.1M invested in Korro Bio in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 18 increasing their positions, 28 reducing their positions, and 20 closing their positions.
531% more call options, than puts
Call options by funds: $164K | Put options by funds: $26K
15% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 20
4% more funds holding
Funds holding: 82 → 85 (+3)
0.12% less ownership
Funds ownership: 1.02% → 0.91% (-0.12%)
36% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 28
60% less capital invested
Capital invested by funds: $95M → $38.1M (-$57M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.04M |
| 2 |
BlackRock
New York
|
+$981K |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$638K |
| 4 |
Mariner
Overland Park,
Kansas
|
+$491K |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$331K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
-$3.63M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$3.29M |
| 3 |
SDIC
South Dakota Investment Council
Sioux Falls,
South Dakota
|
-$2.38M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$806K |
| 5 |
Morgan Stanley
New York
|
-$567K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EVM
101
Eaton Vance Management
Boston,
Massachusetts
| – | -$5K | -20 | Closed |
|
|
RPCONE
102
Retirement Planning Company of New England
Warwick,
Rhode Island
| – | -$2K | -8 | Closed |
|
|
CAL
103
Capital Advisors Ltd
Shaker Heights,
Ohio
| – | -$1K | -4 | Closed |
|
104
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | +$764 | +4 | New |
|
KRRO Hedge Fund Activity: Q1 2022 in Review
85 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q1 2022, worth a combined $38.1M — down 60% from $95M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new KRRO positions and 20 closed out — a net gain of 3 holders — while 18 added to existing stakes and 28 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $1.04M. The largest seller was Lombard Odier Asset Management (Switzerland), exiting entirely with an estimated $3.63M sold.
- 85 institutional investors held Korro Bio (KRRO) as of Q1 2022, up from 82 in Q4 2021.
- Funds reported $38.1M of Korro Bio stock for Q1 2022, down 60% quarter-over-quarter.
- 23 funds opened new Korro Bio positions in Q1 2022 and 20 closed out, a net change of +3 holders.
- The largest Korro Bio buyer in Q1 2022 was Renaissance Technologies, an estimated $1.04M added.
- The largest Korro Bio seller in Q1 2022 was Lombard Odier Asset Management (Switzerland), an estimated $3.63M sold.
Based on aggregated 13F filings for Q1 2022.